Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.
Cancer Immunol Immunother
; 71(2): 301-310, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-34152439
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peptides
/
Protein Precursors
/
Urinary Bladder Neoplasms
/
Transforming Growth Factor beta
/
Chemotherapy, Adjuvant
/
CD8-Positive T-Lymphocytes
/
Muscle Neoplasms
/
Drug Resistance, Neoplasm
/
Tumor Microenvironment
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: